Coverage complications are not unusual in the U.S. health care system. But the challenge is magnified for these obesity ...
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
Senators questioned Novo Nordisk CEO Lars Jørgensen on Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs, which are cheaper in other countries. The CEO of ...
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...
Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
Doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback